Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Wolf

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Planta Medica|February 22, 2018
Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent CellsSven Stadlbauer, Carmen Steinborn, Amy Klemd, et al.
The Prostate|October 15, 2010
Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabodyKerstin Fortmüller, Karen Alt, Dorothee Gierschner, et al.
Immunotherapy|December 22, 2012
Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cellsVolker Baum, Patrick Bühler, Dorothee Gierschner, et al.
Cancers|June 26, 2020
An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer CellsAnie P Masilamani, Viviane Dettmer-Monaco, Gianni Monaco, et al.
International Journal of Molecular Sciences|April 5, 2020
Biofabrication of SDF-1 Functionalized 3D-Printed Cell-Free Scaffolds for Bone Tissue RegenerationAlina Lauer, Philipp Wolf, Dorothea Mehler, et al.
Anticancer Research|July 20, 2021
Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder CancerAnie Priscilla Masilamani, Alexandra Fischer, Susanne Schultze-Seemann, et al.
Anticancer Research|May 31, 2024
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane AntigenSarah Waibel, Nele Graf, Jonas Storz, et al.
The Prostate|March 11, 2014
Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibodyStefan Wiehr, Patrick Bühler, Dorothee Gierschner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cellsPatrick Bühler, Eszter Molnar, Elaine P Dopfer, et al.
Molecules (Basel, Switzerland)|December 31, 2025
Exploring EGFR, Nectin-4, and TROP-2 as Therapeutic Targets for Bladder Cancer PhotoimmunotherapyIsis Wolf, Nora Giess, Céline Roider, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Planta Medica|February 22, 2018
Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent CellsSven Stadlbauer, Carmen Steinborn, Amy Klemd, et al.
The Prostate|October 15, 2010
Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabodyKerstin Fortmüller, Karen Alt, Dorothee Gierschner, et al.
Immunotherapy|December 22, 2012
Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cellsVolker Baum, Patrick Bühler, Dorothee Gierschner, et al.
Cancers|June 26, 2020
An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer CellsAnie P Masilamani, Viviane Dettmer-Monaco, Gianni Monaco, et al.
International Journal of Molecular Sciences|April 5, 2020
Biofabrication of SDF-1 Functionalized 3D-Printed Cell-Free Scaffolds for Bone Tissue RegenerationAlina Lauer, Philipp Wolf, Dorothea Mehler, et al.
Anticancer Research|July 20, 2021
Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder CancerAnie Priscilla Masilamani, Alexandra Fischer, Susanne Schultze-Seemann, et al.
Anticancer Research|May 31, 2024
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane AntigenSarah Waibel, Nele Graf, Jonas Storz, et al.
The Prostate|March 11, 2014
Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibodyStefan Wiehr, Patrick Bühler, Dorothee Gierschner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cellsPatrick Bühler, Eszter Molnar, Elaine P Dopfer, et al.
Molecules (Basel, Switzerland)|December 31, 2025
Exploring EGFR, Nectin-4, and TROP-2 as Therapeutic Targets for Bladder Cancer PhotoimmunotherapyIsis Wolf, Nora Giess, Céline Roider, et al.
Pageof 8